KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 117 filers reported holding KYMERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,141 | -38.3% | 40,154 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $904,450 | -32.7% | 39,341 | -13.3% | 0.00% | -50.0% |
| Q1 2023 | $1,344,817 | +21.4% | 45,387 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $1,107,750 | +16.0% | 44,381 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $955,000 | +9.0% | 43,862 | -1.4% | 0.00% | +100.0% |
| Q2 2022 | $876,000 | -46.7% | 44,491 | +14.7% | 0.00% | -50.0% |
| Q1 2022 | $1,642,000 | -38.9% | 38,801 | -8.4% | 0.00% | -33.3% |
| Q4 2021 | $2,689,000 | +11.8% | 42,354 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $2,406,000 | +24.5% | 40,964 | +2.8% | 0.00% | +50.0% |
| Q2 2021 | $1,933,000 | +227.1% | 39,855 | +162.1% | 0.00% | +100.0% |
| Q1 2021 | $591,000 | -37.5% | 15,204 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $946,000 | – | 15,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |